Preterm birth (PTB), which occurs in about 12% of pregnancies worldwide, is the main cause
of neonatal morbidity and mortality. Symptomatic treatment of pregnancies presenting in …

OBJECTIVE: To determine whether the use of vaginal progesterone in asymptomatic women
with a sonographic short cervix (≤ 25 mm) in the midtrimester reduces the risk of preterm …

Background Preterm birth is a global health priority. Using a progestogen during high-risk
pregnancy could reduce preterm birth and adverse neonatal outcomes. Methods We did a …

Objectives Women with a sonographic short cervix in the mid‐trimester are at increased risk
for preterm delivery. This study was undertaken to determine the efficacy and safety of using …

Objective To determine the risks of stillbirth and neonatal complications by gestational age
in uncomplicated monochorionic and dichorionic twin pregnancies. Design Systematic …

Although progesterone given prophylactically to women with a history of preterm birth cuts
the recurrence rate in half, only about 10% of spontaneous early preterm births take place in …

Background Preterm birth is a major complication of pregnancy associated with perinatal
mortality and morbidity. Progesterone for the prevention of preterm labour has been …

Background In women with a multiple pregnancy, spontaneous preterm delivery is the
leading cause of perinatal morbidity and mortality. Interventions to reduce preterm birth in …

OBJECTIVE: We sought to provide evidence-based guidelines for using progestogens for
the prevention of preterm birth (PTB). METHODS: Relevant documents, in particular …

Although preterm birth (at< 37 weeks' gestation) is sometimes indicated for the health of the
mother or her fetus, spontaneous preterm births occur as a consequence of spontaneous …